INVEST GENERATIONALLY
TOWER INVESTS IN PREMIUM GENERATIONAL HEALTH INNOVATIONS
SPORTS SCIENCE SPOTLIGHT
GENERATIONAL SPORTS SCIENCE
For generations, sport has been one of the clearest demonstrations of human potential. Today, innovations first developed to help athletes recover, perform, and extend their careers are increasingly shaping the future of healthcare, longevity, and quality of life.
TOWER is globally known as the pioneer of Generational Health. As a key funding stakeholder it is launching a first in kind Generational Sports Science Initiative allocating capital toward the science of human performance, long-term health, and technologies with the potential to benefit athletes and broader communities. Uniquely, this funding initiative is first of its kind:
A Generational Health lens for sport, redirecting capital toward the science of human biological performance, with a lens for underserved segments, in a market where 97% of sports investment focuses on teams, venues, media, brands, and accessories.
An athlete-centered ownership model, elevating athletes from endorsers to investment partners with meaningful participation in owning and shaping investment outcomes.
Exposure to the future of human performance science, investing in bioresilience in science for recovery and rehabilitation, musculoskeletal health, brain health, women's performance health, artificial intelligence, regenerative medicine, longevity science, precision diagnostics, and next-generation healthcare technologies.
Alignment with one of the world's largest unmet health needs, addressing the more than 1.7 billion people globally living with musculoskeletal conditions while supporting innovations that help populations maintain physical, cognitive, and metabolic vitality as they age, both elite athletes and kids in communities.
Institutional expertise and global operating reach, drawing on a network spanning $28B+ in Generational Health assets by total invested capital, a dealbook of 1,000+ vetted innovations, operating leadership across five continents, and 175+ years of combined experience, including 40+ medicines launched and experience across multiple exit types.
TOWER is bringing together athletes, innovators, investors, and strategic partners around this opportunity.
TOWER HQ
57 West 57th Street
New York, NY 10019
© 2026. All rights reserved.
Questions? Please contact us directly by requesting access.
By accessing this and all pages on towerinvests.com you agree to abide by TOWER notices.
CONFIDENTIALITY & REGULATORY DISCLOSURE
Confidentiality Notice: This online message, including any attachments, contains information that may be confidential, proprietary, privileged, or otherwise legally protected from disclosure. It is intended solely for the use of the individual(s) or entity named above. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or taking of any action in reliance on the contents of this electronic information is strictly prohibited.
No Offer or Solicitation: This communication is for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security or investment product, which can only be made by human delivery of a Private Placement Memorandum (PPM) or Subscription Agreement. Past performance is not indicative of future results. Investments in private funds are speculative, involve a high degree of risk, and are intended only for sophisticated investors who meet specific suitability requirements.
No Advice: Nothing contained in this email constitutes investment, legal, tax, or other advice. Recipients should consult their own professional advisors prior to making any investment decisions. TOWER CAPITAL GROUP LLC and its affiliates, do not guarantee the accuracy, completeness, or timeliness of any information contained herein, which is subject to change without notice.